US5492697A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Biodegradable implant for fracture nonunions
Assignee: The University of Texas System
•
Filing: 1995-03-13
•
Granted: 1996-02-20
•
Expires: 2015-03-13
Abstract
Abstract A biodegradable implant for placement in nonunion bone fractures as a substitute for bone graft material is provided which is a flat plate or disk having a thickness of between about 1 mm and about 15% of the length of the bone, interconnected micropores, and canals substantially equivalent in size and spacing to naturally-occurring Haversian canals. The implant may additionally comprise additives such as growth factors, including bone morphogenic protein. In a preferred embodiment the implant is formed from a biodegradable polymer such as a polylactic acid-polyglycolic acid copolymer by a gel casting technique followed by solvent extraction to precipitate the implant as a microporous solid.
Inventors
- 👤 Barbara D. Boyan
- 👤 Chandra M. Agrawal
- 👤 James D. Heckman
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 04:22
CPC Classifications
A; A61; A61L; A61L27/00; A61L27/50; A61L27/56; A61F; A61F2/00; A61F2/02; A61F2/28; A61L27/14; A61L27/18; A61L27/58; C; C08; C08J; C08J9/00; C08J9/28; A61F2/30; A61F2/3094; A61F2002/2835; A61F2002/30001; A61F2002/30003; A61F2002/30004; A61F2002/3006; A61F2002/30062; A61F2002/30065; A61F2002/30108; A61F2002/3011; A61F2002/30112; A61F2002/30113; A61F2002/30199; A61F2002/302; A61F2002/30224; A61F2002/30225; A61F2002/30667; A61F2002/30677; A61F2/30767; A61F2/30771; A61F2002/30772; A61F2002/30784; A61F2002/30785; A61F2210/00; A61F2210/0004; A61F2210/0071; A61F2230/00; A61F2230/0002; A61F2230/0004; A61F2230/0006; A61F2230/0063; A61F2230/0065; A61F2230/0069; A61F2250/00; A61F2250/0014; A61L2430/00; A61L2430/02; C08J2367/00; C08J2367/04
Claims Analysis
Total Claims: 21
Claim 1
Independent Claim
96 words
An implant for placement in nonunion bone fractures comprising: a. interconnected pores having an average diameter of between about 5 μm and about 20 μm constituting a void volume of between about 40 and about 85 percent of said implant; b. canals having a size, shape and spacing substantially corresponding to Haversian canals; c. having a thickness of between about 1 mm and about 15% of the length of the bone; d. having a perimeter shaped to substantially correspond to the cross-section of the ends of said nonunion bone fracture; e. having a carvable, non-friable consistency.
Claim 2
Dependent Claim
96 words
An implant for placement in nonunion bone fractures comprising: a. interconnected pores having an average diameter of between about 5 μm and about 20 μm constituting a void volume of between about 40 and about 85 percent of said implant; b. canals having a size, shape and spacing substantially corresponding to Haversian canals; c. having a thickness of between about 1 mm and about 15% of the length of the bone; d. having a perimeter shaped to substantially correspond to the cross-section of the ends of said nonunion bone fracture; e. having a carvable, non-friable consistency.
Claim 3
Dependent Claim
10 words
The implant of claim 1 composed of a bioerodible polymer.
Claim 4
Dependent Claim
12 words
The implant of claim 2 composed of a bioerodible polymer comprising PLA.
Claim 5
Dependent Claim
17 words
The implant of claim 3 composed of a bioerodible polymer comprising a copolymer of PLA and PGA.
Claim 6
Dependent Claim
10 words
The implant of claim 1 having a substantially circular perimeter.
Claim 7
Dependent Claim
22 words
The implant of claim 1 also comprising a central channel therethrough having a diameter of between about 7 and about 35 mm.
Claim 8
Dependent Claim
31 words
The implant of claim 1 further comprising an additive selected from the group consisting of therapeutically active substances, degradation enhancers, degradation retardants, antibiotics, growth hormones, enzymes, immune modulators, vaccines, and medicaments.
Claim 9
Dependent Claim
8 words
The implant of claim 1 also comprising BMP.
Claim 10
Dependent Claim
23 words
The implant of claim 7 further comprising a degradation retardant which is a non-immunogenic protein having a molecular weight at least about 15,000.
Claim 11
Dependent Claim
12 words
The implant of claim 1 produced by a polymer gel casting method.
Claim 12
Dependent Claim
20 words
The implant of claim 10 comprising a PLA:PGA copolymer having a molecular weight of between about 45,000 and about 200,000.
Claim 13
Dependent Claim
50 words
The implant of claim 10 formed by a process comprising: a. solubilizing said polymer in an organic solvent to form a solution; b. allowing said solution to gel in a mold to form said implant; c. removing said gel from said mold; d. removing said organic solvent from said gel.
Claim 14
Dependent Claim
23 words
The implant of claim 12 made by a process wherein said organic solvent is removed from said gel by means of solvent extraction.
Claim 15
Dependent Claim
45 words
The implant of claim 7 designed to release between about half and about two-thirds of said additive within the first two days of implantation in vivo and thereafter to continuously release a substantially constant amount of said additive over the degradation period of said implant.
Claim 16
Independent Claim
103 words
A method for treating a nonunion bone fracture comprising placing into said fracture an implant comprising: a. interconnected pores having an average diameter of between about 5 μm and about 20 μm constituting a void volume of between about 40 and about 85 percent of said implant; b. canals having a size, shape and spacing substantially corresponding to Haversian canals; c. having a thickness of between about 1 mm and about 15% of the length of the bone; d. having a perimeter shaped to substantially correspond to the cross-section of the ends of said nonunion bone fracture; e. having a carvable, non-friable consistency.
Claim 17
Independent Claim
103 words
A method for treating a nonunion bone fracture comprising placing into said fracture an implant comprising: a. interconnected pores having an average diameter of between about 5 μm and about 20 μm constituting a void volume of between about 40 and about 85 percent of said implant; b. canals having a size, shape and spacing substantially corresponding to Haversian canals; c. having a thickness of between about 1 mm and about 15% of the length of the bone; d. having a perimeter shaped to substantially correspond to the cross-section of the ends of said nonunion bone fracture; e. having a carvable, non-friable consistency.
Claim 18
Independent Claim
106 words
A method of making an implant for treating a nonunion bone fracture comprising: a. solubilizing a biodegradable polymer precursor in an organic solvent to form a solution; b. allowing said solution to gel in a mold comprising tines spaced to form canals in said implant having a size, shape and spacing substantially corresponding to Haversian canals; c. removing said gel from said mold; d. removing said organic solvent from said gel by solvent extraction whereby said polymer precipitates as a microporous solid implant having pores about 5 to about 20 μm and forming a void volume between about 40 and about 85 percent of said implant.
Claim 19
Independent Claim
106 words
A method of making an implant for treating a nonunion bone fracture comprising: a. solubilizing a biodegradable polymer precursor in an organic solvent to form a solution; b. allowing said solution to gel in a mold comprising tines spaced to form canals in said implant having a size, shape and spacing substantially corresponding to Haversian canals; c. removing said gel from said mold; d. removing said organic solvent from said gel by solvent extraction whereby said polymer precipitates as a microporous solid implant having pores about 5 to about 20 μm and forming a void volume between about 40 and about 85 percent of said implant.
Claim 20
Dependent Claim
40 words
The method of claim 16 also comprising adding an additive selected from the group consisting of therapeutically active substances, degradation enhancers, degradation retardants, antibiotics, and growth hormones to said solution of step a. prior to allowing said solution to gel.
Claim 21
Dependent Claim
25 words
The method of claim 17 comprising rotating said mold during step b. whereby said active substance remains evenly distributed throughout said solution during gel formation.
References Cited (Backward Citations)
US5290494A
Cited
US5397572A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1999-02-19 | 1999-08-21 | 2000-02-20 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2003-02-19 | 2003-08-21 | 2004-02-20 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2007-02-19 | 2007-08-21 | 2008-02-20 | $7700.00 | Window Closed / Lapsed |